01 5GILEAD SCIENCES INC
02 1JANSSEN PRODS
03 6VIIV HLTHCARE
01 18129385
02 18754065
03 19242986
04 19296769
05 110426780
06 110857102
07 111065198
08 112011506
09 18129385*PED
10 18754065*PED
11 19242986*PED
12 19296769*PED
01 5Y
02 7Blank
01 8Y
02 4Blank
01 12027-10-05
02 12028-04-05
03 12029-12-08
04 12030-06-08
05 12031-01-24
06 22032-08-15
07 12033-01-14
08 22033-02-15
09 12037-10-23
10 12038-09-05
Patent Expiration Date : 2032-08-15
EMTRICITABINE; RILPIVIRINE HYDROCHLORIDE; TENOFOVIR ALAFENAMIDE FUMARATE
US Patent Number : 9296769
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 208351
Patent Use Code : U-257
Delist Requested :
Patent Use Description : TREATMENT OF HIV INFEC...
Patent Expiration Date : 2032-08-15
Patent Expiration Date : 2032-08-15
EMTRICITABINE; RILPIVIRINE HYDROCHLORIDE; TENOFOVIR ALAFENAMIDE FUMARATE
US Patent Number : 8754065
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 208351
Patent Use Code : U-257
Delist Requested :
Patent Use Description : TREATMENT OF HIV INFEC...
Patent Expiration Date : 2032-08-15
Patent Expiration Date : 2033-01-14
EMTRICITABINE; RILPIVIRINE HYDROCHLORIDE; TENOFOVIR DISOPROXIL FUMARATE
US Patent Number : 10857102
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 202123
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2033-01-14
Patent Expiration Date : 2033-02-15
EMTRICITABINE; RILPIVIRINE HYDROCHLORIDE; TENOFOVIR ALAFENAMIDE FUMARATE
US Patent Number : 8754065*PED
Drug Substance Claim :
Drug Product Claim :
Application Number : 208351
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2033-02-15
Patent Expiration Date : 2033-02-15
EMTRICITABINE; RILPIVIRINE HYDROCHLORIDE; TENOFOVIR ALAFENAMIDE FUMARATE
US Patent Number : 9296769*PED
Drug Substance Claim :
Drug Product Claim :
Application Number : 208351
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2033-02-15
Patent Expiration Date : 2037-10-23
US Patent Number : 11065198
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 219016
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2037-10-23
Patent Expiration Date : 2031-01-24
DOLUTEGRAVIR SODIUM; RILPIVIRINE HYDROCHLORIDE
US Patent Number : 10426780
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 210192
Patent Use Code : U-257
Delist Requested :
Patent Use Description : TREATMENT OF HIV INFEC...
Patent Expiration Date : 2031-01-24
Patent Expiration Date : 2029-12-08
DOLUTEGRAVIR SODIUM; RILPIVIRINE HYDROCHLORIDE
US Patent Number : 9242986
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 210192
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2029-12-08
Patent Expiration Date : 2038-09-05
DOLUTEGRAVIR SODIUM; RILPIVIRINE HYDROCHLORIDE
US Patent Number : 12011506
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 210192
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2038-09-05
Patent Expiration Date : 2027-10-05
DOLUTEGRAVIR SODIUM; RILPIVIRINE HYDROCHLORIDE
US Patent Number : 8129385
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 210192
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2027-10-05
